Dosage form comprising oxybutynin

Details Dosage form comprising oxybutynin Dosage form comprising oxybutynin

1996-09-05

1998-11-24

Seidleck, James J.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Ester doai

424464, 424468, 424474, 424475, 424479, 424480, 424484, 424486, 424488, A01N 3744

Patent

active

058407545

ABSTRACT:
A composition comprising oxybutynin, a device comprising oxybutynin, and a method for administering oxybutynin are disclosed for oxybutynin therapy.

REFERENCES:
patent: 3845770 (1974-11-01), Theeuwes et al.
patent: 3916899 (1975-11-01), Theeuwes et al.
patent: 4063064 (1977-12-01), Saunders et al.
patent: 4088864 (1978-05-01), Theeuwes et al.
patent: 4111202 (1978-09-01), Theeuwes et al.
patent: 4200098 (1980-04-01), Ayer et al.
patent: 4285987 (1981-08-01), Ayer et al.
patent: 4327725 (1982-05-01), Cortese et al.
patent: 4612008 (1986-09-01), Wong et al.
patent: 4783337 (1988-11-01), Wong et al.
patent: 4816263 (1989-03-01), Ayer et al.
patent: 4824675 (1989-04-01), Wong et al.
patent: 4863456 (1989-09-01), Stephens et al.
patent: 4902514 (1990-02-01), Barclay et al.
patent: 5674895 (1997-10-01), Guitiard et al.
"General principles for designing with plastics" by P. Grafton, 1969-1970 Modern Plastics Encyclopedia, vol. 46, pp. 62-71.
"Preparation of Compressed Tablet Granulations by the Air-Suspension Technique II" by Dale E. Wurster, J. of Amerc. Phar. Association vol. 49 No. 2, pp. 82-84 , Feb. 1960.
"Air-Suspension Technique of Coating Drug Particles" by Dale E. Wurster, J. Am Phar. Assoc. Sci. Ed., vol. 48, pp. 451-454, Aug. 1959.
Pharmaceutical Science, By Remington, 14th Ed., pp. 1626-1679 (1970).

Affiliated with

Also associated with

Rating

Dosage form comprising oxybutynin does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Dosage form comprising oxybutynin, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Dosage form comprising oxybutynin will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1702651